Higher expression of GIT2 in AAA patients in relation to LEAD subjects (Table 2) suggests enhanced association of aging hallmarks with AAA pathogenesis in comparison to LEAD, what is especially suggestive, because individuals in the AAA and LEAD groups have similar age. The gene discussed is GIT2; the disease is triple-A syndrome.